Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
Titel:
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
Auteur:
Jiang, Yi-Zhou Ge, Li-Ping Jin, Xi Fan, Lei He, Min Liu, Yin Chen, Li Zuo, Wen-Jia Wu, Jiong Liu, Guang-Yu Di, Gen-Hong Wang, Zhong-Hua Yu, Ke-Da Shao, Zhi-Ming